Posted 21 December 2017
A complaint was laid with the UK ASA. The complainant, an inspector for the Care Quality Commission, challenged whether the efficacy claims that hyperbaric oxygen therapy could treat the following were misleading and could be substantiated: burns, chronic fatigue, fibromyalgia, hearing loss, interstitial cystitis, leg ulcers, peripheral neuropathy, referred pain, sciatica, varicose ulcers and varicose veins, Addison’s and Hasimoto’s diseases, anaemia, diabetes, brain injuries, candida, carbon monoxide poisoning, cognitive disorders in the elderly, heart attacks, infertility and IVF, Lymes [sic] disease, migraines, motor neurone disease, MRSA, multiple sclerosis, stroke recovery, Parkinson’s disease, prostatitis, soft tissue infections and urine infections.
We (UK ASA) considered that a suitable body of evidence would be required to support each of the claims. The Hyperbaric Oxygen Therapy Centre did not provide any evidence to support their claims that HBOT could be used to treat . . .
https://www.asa.org.uk/rulings/hyperbaric-oxygen-therapy-ltd-a17-383407.html
… Read the rest